Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Exscientia plc (EXAI)

5.3   0 (0%) 03-31 16:00
Open: 5.28 Pre. Close: 5.3
High: 5.43 Low: 5.25
Volume: 200,437 Market Cap: 654(M)

Technical analysis

as of: 2023-03-31 4:18:32 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 7.43     One year: 8.36
Support: Support1: 5.07    Support2: 4.21
Resistance: Resistance1: 6.36    Resistance2: 7.15
Pivot: 6.18
Moving Average: MA(5): 5.44     MA(20): 6.28
MA(100): 6.32     MA(250): 8.73
MACD: MACD(12,26): -0.4     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 16.9     %D(3): 17.5
RSI: RSI(14): 39.4
52-week: High: 16.45  Low: 4.09
Average Vol(K): 3-Month: 299 (K)  10-Days: 350 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ EXAI ] has closed above bottom band by 12.4%. Bollinger Bands are 4.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.74 - 5.77 5.77 - 5.8
Low: 5.06 - 5.1 5.1 - 5.13
Close: 5.24 - 5.3 5.3 - 5.35

Company Description

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.

Headline News

Thu, 23 Mar 2023
Exscientia Business and Financial Update for the Full Year 2022 - Business Wire

Thu, 16 Mar 2023
Exscientia to Report Full Year 2022 Financial Results on March 23 ... - Tullahoma News and Guardian

Thu, 16 Mar 2023
Short Volatility Alert: Exscientia Plc - Exscientia (NASDAQ:EXAI) - Benzinga

Wed, 15 Mar 2023
Exscientia to Present Data Highlighting Pipeline and Precision ... - Business Wire

Sat, 11 Mar 2023
Exscientia plc's (NASDAQ:EXAI) market cap dropped US$65m last week; individual investors who hold 57% were hit as were institutions - Simply Wall St

Tue, 07 Mar 2023
Exscientia Announces Collaboration with Charité to Advance ... - Business Wire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 123 (M)
Shares Float 104 (M)
% Held by Insiders 16.2 (%)
% Held by Institutions 28.7 (%)
Shares Short 2,290 (K)
Shares Short P.Month 1,870 (K)

Stock Financials

EPS -1.56
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.15
Profit Margin (%) 0
Operating Margin (%) -585.7
Return on Assets (ttm) -18.4
Return on Equity (ttm) -26.8
Qtrly Rev. Growth -64.4
Gross Profit (p.s.) 0.08
Sales Per Share 0.19
EBITDA (p.s.) -1.12
Qtrly Earnings Growth 0
Operating Cash Flow -28 (M)
Levered Free Cash Flow -58 (M)

Stock Valuations

PE Ratio -3.4
PEG Ratio 0
Price to Book value 1.27
Price to Sales 26.52
Price to Cash Flow -23.56

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.